
201 - 500 employees
🏥 Healthcare
🧬 Biotechnology
💰 $30M Venture Round - Vero Biotech on 2023-01
Healthcare • Biotechnology
VERO Biotech is a life sciences company that develops and commercializes inhaled nitric oxide (iNO) delivery systems to improve patient respiratory outcomes. Its flagship product, the GENOSYL® Delivery System (DS), is a tankless iNO device approved for use across care areas — including neonatal and anesthesia/surgical settings — and is indicated to improve oxygenation and reduce the need for ECMO in term and near-term neonates with hypoxic respiratory failure associated with pulmonary hypertension. VERO also provides clinician-focused services (Partnership365) offering 24/7 respiratory therapist support, training, inventory management, and technical and medical support to healthcare providers.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 July 28
Account Executive at Vero Biotech developing innovative technologies in acute care respiratory therapy. Qualifying accounts and providing training in hospital environments with a focus on sales growth.
🐊 Florida – Remote
💰 $30M Venture Round - Vero Biotech on 2023-01
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧑💼 Account Executive
👻 Ghost score 18%
🗣️🇪🇸 Spanish Required